Connected Catheter Clinical Feasibility Study( CFS)

Status Completed

Clinical Trial Summary

The objective of this study is to evaluate the safety and essential performance of the Connected Catheter System in males with neurogenic lower urinary tract dysfunction (NLUTD), both in an acute clinical setting, and during and extended period (up to 29 days) of home use.

Clinical Trial Description

The Connected Catheter (C2P) is a replaceable urinary prosthesis that is intended for use in male patients 18 years of age or older who have impaired bladder emptying due to neurogenic lower urinary tract dysfunction, and who are capable of operating the device in accordance with the provided instructions for use, or who have trained caregivers capable of doing the same. The device must be replaced every 29 days ;

Study Design

Related Conditions & MeSH terms

Urinary Bladder, Neurogenic

Clinical Trial Details

NCT number	NCT03405285
Study type	Interventional
Source	Spinal Singularity
Contact
Status	Completed
Phase	N/A
Start date	February 28, 2018
Completion date	June 30, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05141487` - Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
Completed	`NCT01920243` - Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI)	N/A
Completed	`NCT04528784` - Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis	N/A
Enrolling by invitation	`NCT03336424` - Urinary Disorders in Patients With Multiple Sclerosis: Invasive Vs Non-invasive Investigations.	N/A
Not yet recruiting	`NCT05075642` - Multicenter Observational Study for the Evaluation in Clinical Practice of Urinary Disorders in Multiple Sclerosis
Completed	`NCT02600715` - Reduction of Bladder Injection Pain With Belladonna Opiate Suppository	Phase 4
Recruiting	`NCT04128709` - Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use	N/A
Not yet recruiting	`NCT06336304` - NXT Post-Market Clinical Follow-up
Enrolling by invitation	`NCT05740527` - Ambulatory Closed-loop Stimulation for Bladder Control	N/A
Completed	`NCT02501928` - Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.	Phase 3
Recruiting	`NCT04819360` - Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis	Phase 4
Terminated	`NCT02044510` - Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients	Phase 2/Phase 3
Completed	`NCT01557244` - A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition	Phase 3
Recruiting	`NCT05380661` - Heart Rate Variability and Anxiety During Urinary Bladder Catheterization	N/A
Recruiting	`NCT04193709` - Recovery of Bladder and Sexual Function After Human Spinal Cord Injury	N/A
Completed	`NCT02582151` - Transcutaneous Peripheral Neuromodulation for Neurogenic Bladder	N/A
Active, not recruiting	`NCT05232253` - Cystoealstometer (Bladder Monitor Device)-Home Use	N/A
Completed	`NCT02673047` - Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder	N/A
Completed	`NCT01773213` - Detrusor Contraction During the Ice-water-test	N/A
Completed	`NCT01530620` - Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity	Phase 3